Nov 12, 2021
Calciscon congratulates researchers from the University of Vienna on an important publication with the T50 test!
The T50 test measures calcification propensity in blood. It was developed for patients with chronic renal insufficiency (CNI). Researchers at the University of Vienna have now used the T50 test for the first time in patients with peripheral arterial disease (PAD) without CNI.

T50 was associated with cardiovascular events and death in PAD. This association was independent of established cardiovascular risk factors such as hypertension, diabetes, and cholesterol.

This is exciting news as it indicates a clinical utility of the T50 test beyond CNI. Congratulations on this great work!
© 2024 by CALCISCON | Privacy Policy